BIO vs IQV · rev $651.0M vs P/E 23, rev $16.31B
BIO (BIO) versus IQVIA Holdings Inc (IQV) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
IQVIA Holdings Inc (IQV) is a diagnostics & research company listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported IQV revenue for 2025-12-31 was $16.31B. Net income was $1.36B. Revenue was up 5.9% from 2024-12-31 to 2025-12-31. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
BIO currently screens at market cap $0. IQV currently screens at market cap $30.62B and trailing P/E 22.8.
Not investment advice. Open the BIO and IQV stock pages for the full models.
Not investment advice.